ARTICLE | Clinical News
Detrol LA tolterodine ER: Phase IV discontinued
July 16, 2012 7:00 AM UTC
Pfizer said it discontinued enrollment in the double-blind, placebo-controlled, U.S. Phase IV REMOTE trial evaluating daily 4 mg Detrol LA after the enrollment rate did not meet its expectations. The ...